SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
05-Aug-24 4:49 PM View: | Cerevel Therapeutics Holdin... (CERE) | 01-Aug-24 | Disposition | 13,743 | -- | -- | (< 1%) 65.69M to 65.68M | |
05-Aug-24 4:49 PM View: | Cerevel Therapeutics Holdin... (CERE) | 01-Aug-24 | Disposition | 65,679,800 | -- | -- | (100%) 65.68M to 0 | |
07-Jun-24 5:12 PM View: | Cerevel Therapeutics Holdin... (CERE) | 05-Jun-24 | Grant | 10,461 | -- | -- | < 1% 65.68M to 65.69M | |
12-Jan-24 4:56 PM View: | Solid Biosciences Inc. (SLDB) | 11-Jan-24 | Grant | 904,160 | $5.53 | $5,000,000.00 | 29% 3.13M to 4.03M | |
18-Oct-23 4:30 PM View: | Cerevel Therapeutics Holdin... (CERE) | 16-Oct-23 | Purchase Duplicate | 5,480,050 | $22.81 | $125,000,000.00 | 9% 60.2M to 65.68M | |
09-Jun-23 5:07 PM View: | Cerevel Therapeutics Holdin... (CERE) | 07-Jun-23 | Grant | 3,282 | -- | -- | < 1% 60.63M to 60.64M | |
09-Jun-23 5:07 PM View: | Cerevel Therapeutics Holdin... (CERE) | 07-Jun-23 | Disposition (other) | 432,627 | -- | -- | (< 1%) 60.64M to 60.2M | |
29-Dec-21 4:43 PM View: | Dicerna Pharmaceuticals Inc (DRNA) | 28-Dec-21 | Disposition (change in control) | 3,333 | $38.25 | $127,487.00 | (< 1%) 3.08M to 3.08M | < 1% |
29-Dec-21 4:43 PM View: | Dicerna Pharmaceuticals Inc (DRNA) | 28-Dec-21 | Disposition (change in control) | 3,080,240 | $38.25 | $117,819,000.00 | (100%) 3.08M to 0 | < 1% |
07-Jun-21 6:50 PM View: | Dicerna Pharmaceuticals Inc (DRNA) | 03-Jun-21 | Option Exercise | 3,333 | -- | -- | < 1% 3.08M to 3.08M | |
25-Mar-21 10:00 PM View: | Solid Biosciences Inc. (SLDB) | 23-Mar-21 | Grant | 869,565 | $5.75 | $5,000,000.00 | 12% 7.06M to 7.93M | (7%) |
14-Dec-20 5:35 PM View: | Dicerna Pharmaceuticals Inc (DRNA) | 10-Dec-20 | Market Sale | 1,000,000 | $23.40 | $23,400,000.00 | (25%) 4.08M to 3.08M | (62%) |
11-Dec-20 4:30 PM View: | Solid Biosciences Inc. (SLDB) | 10-Dec-20 | Grant | 3,189,190 | $3.70 | $11,800,000.00 | 82% 3.87M to 7.06M | 85% |
12-Nov-20 5:54 PM View: | Cerevel Therapeutics Holdin... (CERE) | 09-Nov-20 | Purchase Duplicate | 332,293 | $10.30 | $3,422,620.00 | < 1% 60.3M to 60.63M | |
29-Oct-20 8:00 PM View: | Cerevel Therapeutics Holdin... (CERE) | 27-Oct-20 | Acquisition (other) Duplicate | 49,961,900 | -- | -- | 14776% 338.2K to 50.3M | |
29-Oct-20 8:00 PM View: | Cerevel Therapeutics Holdin... (CERE) | 27-Oct-20 | Purchase Duplicate | 10,000,000 | $10.00 | $100,000,000.00 | 20% 50.3M to 60.3M | |
26-Oct-20 4:30 PM View: | Bcls Acquisition Corp. (BLSA) | 26-Oct-20 | Grant Duplicate | 487,500 | $10.00 | $4,875,000.00 | 100% 0 to 487.5K | |
16-Jan-20 4:20 PM View: | Aptinyx Inc. (APTX) | 14-Jan-20 | Market Purchase | 3,333,330 | $3.00 | $10,000,000.00 | 150% 2.23M to 5.56M | 21% |
06-Dec-19 5:00 PM View: | Dicerna Pharmaceuticals Inc (DRNA) | 04-Dec-19 | Market Sale | 1,500,000 | $24.68 | $37,020,000.00 | (27%) 5.58M to 4.08M | (54%) |
30-Jul-19 4:37 PM View: | Solid Biosciences Inc. (SLDB) | 30-Jul-19 | Grant | 1,881,720 | $4.65 | $8,750,000.00 | 95% 1.99M to 3.87M | |
26-Jun-18 4:50 PM View: | Aptinyx Inc. (APTX) | 25-Jun-18 | Conversion | 1,825,090 | -- | -- | 100% 0 to 1.83M | |
26-Jun-18 4:50 PM View: | Aptinyx Inc. (APTX) | 25-Jun-18 | Purchase | 400,000 | $16.00 | $6,400,000.00 | 22% 1.83M to 2.23M | |
01-Feb-18 7:07 PM View: | Solid Biosciences Inc. (SLDB) | 30-Jan-18 | Purchase | 300,000 | $16.00 | $4,800,000.00 | 18% 1.69M to 1.99M | |
01-Feb-18 7:07 PM View: | Solid Biosciences Inc. (SLDB) | 25-Jan-18 | Option Exercise | 1,689,440 | -- | -- | 100% 0 to 1.69M | |
07-Jun-16 4:09 PM View: | Biogen Idec Inc. (BIIB) | 06-Jun-16 | Market Sale (Planned) | 555 | $290.00 | $160,950.00 | (19%) 2.96K to 2.4K | 3% |
06-Jun-16 8:48 PM View: | Biogen Idec Inc. (BIIB) | 02-Jun-16 | Payment of Exercise | 534 | $289.73 | $154,716.00 | (15%) 3.49K to 2.96K | 2% |
06-Jun-16 8:48 PM View: | Biogen Idec Inc. (BIIB) | 02-Jun-16 | Option Exercise | 1,643 | -- | -- | 89% 1.85K to 3.49K | |
07-Apr-16 5:03 PM View: | Biogen Idec Inc. (BIIB) | 06-Apr-16 | Market Sale (Planned) | 102 | $275.00 | $28,050.00 | (5%) 1.95K to 1.85K | (3%) |
25-Feb-16 5:02 PM View: | Biogen Idec Inc. (BIIB) | 23-Feb-16 | Payment of Exercise | 98 | $258.99 | $25,381.00 | (5%) 1.96K to 1.86K | (9%) |
25-Feb-16 5:02 PM View: | Biogen Idec Inc. (BIIB) | 23-Feb-16 | Option Exercise | 301 | -- | -- | 18% 1.66K to 1.96K | |
04-Jun-15 5:49 PM View: | Biogen Idec Inc. (BIIB) | 02-Jun-15 | Payment of Exercise | 852 | $387.62 | $330,252.00 | (34%) 2.51K to 1.66K | 27% |
04-Jun-15 5:49 PM View: | Biogen Idec Inc. (BIIB) | 02-Jun-15 | Option Exercise | 2,384 | -- | -- | 1834% 0.13K to 2.51K | |
28-Jun-13 5:52 PM View: | Ptc Therapeutics, Inc. (PTCT) | 25-Jun-13 | Conversion | 1,083,330 | -- | -- | 100% 1.08M to 2.17M | |
28-Jun-13 5:52 PM View: | Ptc Therapeutics, Inc. (PTCT) | 25-Jun-13 | Purchase | 1,250,000 | $15.00 | $18,750,000.00 | 58% 2.17M to 3.42M |